2025年 新着論文 35 細胞情報学分野から論文が発表されました

ATG conjugation-dependent/independent mechanisms underlie lysosomal stress-induced TFEB regulation

J Cell Biol. 2025 Oct 6;224(10):e202307079. doi: 10.1083/jcb.202307079. Epub 2025 Aug 29.

Authors

Shiori Akayama #  1   2 Takayuki Shima #  2   3 Tatsuya Kaminishi  4 Mengying Cui  4 Jlenia Monfregola  5 Kohei Nishino  6 Andrea Ballabio  5   7   8   9 Hidetaka Kosako  6 Tamotsu Yoshimori  10 Shuhei Nakamura  2   3

Affiliations

  • 1 Graduate School of Frontier Biosciences, Osaka University , Suita, Japan.
  • 2 Department of Biochemistry, Nara Medical University, Kashihara, Japan.
  • 3 Center for Autophagy and Anti-Aging Research, Nara Medical University , Kashihara, Japan.
  • 4 Graduate School of Medicine, Osaka University , Suita, Japan.
  • 5 Telethon Institute of Genetics and Medicine (TIGEM) , Naples, Italy.
  • 6 Fujii Memorial Institute of Medical Sciences, Institute of Advanced Medical Sciences, Tokushima University , Tokushima, Japan.
  • 7 Department of Translational Medical Sciences, Federico II University, Naples, Italy.
  • 8 Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • 9 Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital , Houston, TX, USA.
  • 10 Department of Beyond Cell Reborn Research, Graduate School of Medicine, The University of Osaka, Suita, Japan.
# Contributed equally.

Abstract

TFEB, a master regulator of autophagy and lysosomal biogenesis, is activated by several cellular stresses including lysosomal damage, but its underlying mechanism is unclear. TFEB activation during lysosomal damage depends on the ATG conjugation system, which mediates lipidation of ATG8 proteins. Here, we newly identify ATG conjugation-independent TFEB regulation that precedes ATG conjugation-dependent regulation, designated Modes I and II, respectively. We reveal unique regulators of TFEB in each mode: APEX1 in Mode I and CCT7 and/or TRIP6 in Mode II. APEX1 interacts with TFEB independently of the ATG conjugation system, and is required for TFEB stability, while both CCT7 and TRIP6 accumulate on lysosomes during lysosomal damage, and interact with TFEB mainly in ATG conjugation system-deficient cells, presumably blocking TFEB activation. TFEB activation by several other stresses also involves either Mode I or Mode II. Our results pave the way for a unified understanding of TFEB regulatory mechanisms from the perspective of the ATG conjugation system under a variety of cellular stresses.

Conflict of interest statement

Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. A. Ballabio reported personal fees from CASMA Therapeutics and personal fees from Avilar Therapeutics outside the submitted work. S. Nakamura reported “I am the cofounder of APGO.” No other disclosures were reported.